Clinical Trial Update: Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the effect of an anti-inflammatory drug on gut mucosa in HIV-infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED